Xue‐Yin Pan

896 total citations
23 papers, 744 citations indexed

About

Xue‐Yin Pan is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Xue‐Yin Pan has authored 23 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Hepatology and 8 papers in Epidemiology. Recurrent topics in Xue‐Yin Pan's work include Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and MicroRNA in disease regulation (4 papers). Xue‐Yin Pan is often cited by papers focused on Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and MicroRNA in disease regulation (4 papers). Xue‐Yin Pan collaborates with scholars based in China. Xue‐Yin Pan's co-authors include Jun Li, Xiao‐Ming Meng, Fangtian Bu, Cheng Huang, Hai-Di Li, Cheng Huang, Xiaofeng Li, Jun Li, Xiaoyu Cheng and Huimin Huang and has published in prestigious journals such as Advanced Functional Materials, Oncogene and Brain Research.

In The Last Decade

Xue‐Yin Pan

23 papers receiving 736 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue‐Yin Pan China 16 395 233 194 185 101 23 744
Núria Tarrats United Kingdom 12 337 0.9× 224 1.0× 83 0.4× 158 0.9× 47 0.5× 13 763
Lingling He China 13 193 0.5× 163 0.7× 97 0.5× 145 0.8× 78 0.8× 52 622
Kelly McDaniel United States 17 309 0.8× 262 1.1× 245 1.3× 249 1.3× 108 1.1× 26 839
István Fűri Hungary 13 359 0.9× 258 1.1× 193 1.0× 69 0.4× 167 1.7× 18 779
Katharina John Germany 13 182 0.5× 157 0.7× 102 0.5× 84 0.5× 60 0.6× 20 533
Yiming Li China 16 401 1.0× 158 0.7× 279 1.4× 114 0.6× 45 0.4× 48 876
Masako Omori Japan 17 259 0.7× 84 0.4× 136 0.7× 151 0.8× 46 0.5× 45 760
Kate Huang China 19 550 1.4× 109 0.5× 365 1.9× 82 0.4× 45 0.4× 42 900
Robert Vincent United States 11 278 0.7× 548 2.4× 78 0.4× 195 1.1× 57 0.6× 15 867

Countries citing papers authored by Xue‐Yin Pan

Since Specialization
Citations

This map shows the geographic impact of Xue‐Yin Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue‐Yin Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue‐Yin Pan more than expected).

Fields of papers citing papers by Xue‐Yin Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue‐Yin Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue‐Yin Pan. The network helps show where Xue‐Yin Pan may publish in the future.

Co-authorship network of co-authors of Xue‐Yin Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xue‐Yin Pan. A scholar is included among the top collaborators of Xue‐Yin Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue‐Yin Pan. Xue‐Yin Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Yong, Jie Bai, Jiaqing Chen, et al.. (2025). Orally Administered Functional Polyphenol‐Nanozyme‐Armored Probiotics for Enhanced Amelioration of Intestinal Inflammation and Microbiota Dysbiosis. Advanced Science. 12(17). e2411939–e2411939. 8 indexed citations
2.
Pan, Xue‐Yin, Qiang Wang, & Beicheng Sun. (2024). Multifaceted roles of neutrophils in tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189231–189231. 2 indexed citations
3.
Bu, Fangtian, Yan Zhu, Xue‐Yin Pan, et al.. (2023). Inhibition of circular RNA ASPH reduces the proliferation and promotes the apoptosis of hepatic stellate cells in hepatic fibrosis. Biochemical Pharmacology. 210. 115451–115451. 6 indexed citations
4.
Jiang, Wei, Yafei Zhang, Yingying Sheng, et al.. (2022). Overexpression of IFIT1 protects against LPS-induced acute lung injury via regulating CCL5-p65NF-κB signaling. International Immunopharmacology. 114. 109485–109485. 7 indexed citations
5.
Wang, Ling, Hongmei You, Xue‐Yin Pan, et al.. (2021). STING‐mediated inflammation contributes to Gao binge ethanol feeding model. Journal of Cellular Physiology. 237(2). 1471–1485. 13 indexed citations
6.
You, Hongmei, Ling Wang, Fangtian Bu, et al.. (2021). The miR‐455‐3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics. The FASEB Journal. 35(7). e21700–e21700. 11 indexed citations
7.
Bi, Yihui, Wenxiu Duan, Jing Chen, et al.. (2021). Neutrophil Decoys with Anti‐Inflammatory and Anti‐Oxidative Properties Reduce Secondary Spinal Cord Injury and Improve Neurological Functional Recovery. Advanced Functional Materials. 31(34). 56 indexed citations
8.
Pan, Xue‐Yin, Ling Wang, Hongmei You, et al.. (2021). Alternative activation of macrophages by prostacyclin synthase ameliorates alcohol induced liver injury. Laboratory Investigation. 101(9). 1210–1224. 18 indexed citations
9.
Chen, Xin, Hai-Di Li, Fangtian Bu, et al.. (2020). Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics. 10(11). 4851–4870. 68 indexed citations
10.
Pan, Xue‐Yin, Cheng Huang, & Jun Li. (2020). The emerging roles of m6A modification in liver carcinogenesis. International Journal of Biological Sciences. 17(1). 271–284. 33 indexed citations
11.
Yu, Haixia, Yao Yao, Fangtian Bu, et al.. (2019). Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells. Molecular Immunology. 107. 29–40. 77 indexed citations
12.
Pan, Xue‐Yin, Hongmei You, Ling Wang, et al.. (2019). Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling. Theranostics. 9(15). 4308–4323. 43 indexed citations
13.
Chen, Xin, Xiaofeng Li, Yu Chen, et al.. (2019). Hesperetin derivative attenuates CCl4-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms. International Immunopharmacology. 76. 105838–105838. 36 indexed citations
14.
Pan, Xue‐Yin, Yang Yang, Hai-Di Li, et al.. (2018). DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis. Frontiers in Pharmacology. 9. 553–553. 27 indexed citations
15.
Wang, Qin, Mingfang Li, Zhiming Shen, et al.. (2018). The Long Non-coding RNA MEG3/miR-let-7c-5p Axis Regulates Ethanol-Induced Hepatic Steatosis and Apoptosis by Targeting NLRC5. Frontiers in Pharmacology. 9. 302–302. 33 indexed citations
16.
Bu, Fangtian, Yu Chen, Haixia Yu, et al.. (2018). SENP2 alleviates CCl4-induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion. Toxicology Letters. 289. 86–98. 24 indexed citations
17.
Li, Wanxia, Yu Chen, Xiaofeng Li, et al.. (2018). Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis. Cell Death and Disease. 9(10). 1021–1021. 53 indexed citations
18.
Chen, Xin, Hai-Di Li, Huimin Huang, et al.. (2017). Hesperetin derivative-14 alleviates inflammation by activating PPAR-γ in mice with CCl4-induced acute liver injury and LPS-treated RAW264.7 cells. Toxicology Letters. 274. 51–63. 36 indexed citations
19.
Cheng, Xiaoyu, Peijie Chen, Xue‐Yin Pan, et al.. (2016). Transmembrane protein 88 attenuates liver fibrosis by promoting apoptosis and reversion of activated hepatic stellate cells. Molecular Immunology. 80. 58–67. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026